BB Biotech 2nd Line Ord Shs (BBZA) Akciju cena un jaunumi

SākumlapaBBZA • FRA

BB Biotech 2nd Line Ord Shs

40,35 €

29. nov., 22:59:48 GMT+1 · EUR · FRA · Atruna

AkcijaVērtspapīrs tiek tirgots šeit: DEGalvenā biroja atrašanās vieta: CH

Slēgšanas kurss

39,80 €

Dienas diapazons

39,30 € - 40,45 €

Gada diapazons

37,60 € - 52,60 €

Tirgus kapitalizāc.

2,05 mljrd. CHF

Vid. apjoms

3,31 tūkst.

P/E koeficients

Ienākumi no dividendēm

Galvenā birža

SWX

Tirgus ziņas

Spogulis Baltic

pirms 1 dienas

Piektdiena noslēdzas ar jauniem rekordiem ASV akciju biržās

TheStreet

pirms 12 stundām

The Trump Trade rally has stocks at record highs. Where do we go from here?

Diversifying Beyond The Vanilla S&P 500: Two ETFs To Watch In 2025

.INX

0,56%

Investor's Business Daily

pirms 4 stundām

Dow Jones Futures: Nvidia, Meta, Apple Eye Buy Points With Tesla FSD v13 Coming

New stock exchange aiming to offer 23-hour trading set to launch in 2025

Yahoo Finance

pirms 1 dienas

3 Magnificent S&P 500 Dividend Stocks Down 27%, 28%, and 29% to Buy and Hold Forever

.INX

0,56%

Par

BB Biotech AG is a Swiss investment company in the field of biotechnology. The company invests mainly in the United States and Western Europe and is managed by Bellevue Asset Management, a division of Bellevue Group, which is listed on the Swiss Stock Exchange. It is one of the largest investment companies in the biotech sector. Wikipedia

Dibināšanas datums

1993. gada 9. nov.

Galvenais birojs

Küsnacht, Cīrihe
Šveice

Tīmekļa vietne

bbbiotech.ch